6-Hydroxydopamine-induced lesions of dopaminergic neurons alter the function of postsynaptic cholinergic neurons without changing cytoskeletal proteins

Experimental Neurology

Volumn 168, Issue 1, 2001, Pages 135-143

  Muma, Nancy A ^a   Lee, John M ^a   Gorman, Linda ^b   Heidenreich, Byron A ^a   Mitrovic, Igor ^a   Napier, T Celeste ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

6 hydroxydopamine; Alzheimer's disease; Dopamine; Lesions; Paired helical filaments; Parkinson's disease; Rat; Tau

Indexed keywords

CYTOSKELETON PROTEIN; DOPAMINE; HEMICHOLINIUM DERIVATIVE; MICROTUBULE ASSOCIATED PROTEIN 2; OXIDOPAMINE; TAU PROTEIN;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL CELL; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LEWY BODY; MALE; MONOAMINE NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NEUROPATHOLOGY; NONHUMAN; PAIRED HELICAL FILAMENT; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

EID: 0035127929     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7582     Document Type: Article

References (48)

1. 1 dopamine receptor distribution after dopaminergic deafferentation
2. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
3. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism
4. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region
5. Chemical Lesioning: Catecholamine Pathways
6. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding
7. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine
8. Primate models of movement disorders of basal ganglia origin
9. Prolonged and selective induction of Fos-related antigen(s) in striatal neurons after 6-hydroxydopamine lesions of the rat substantia nigra pars compacta
10. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease
11. The subthalamic nucleus and its connections, new electrophysiological and pharmacological data
12. Monoclonal antibody AT8 recognnises tau protein phophorylated at both serine 202 and threonin 205
13. Varying degrees of phosphorylation determine microheterogeneity of the heavy neurofilament polypeptide (Nf-H)
14. Efferent connections of the ventral pallidum: Evidence of a dual striato-pallidofugal pathway
15. 6-hydroxydopamine lesion of the rat substantia nigra: Time course and morphology of cell death
16. Differential effects of dopamine depletion on the binding and mRNA levels of dopamine receptors in the shell and core of the rat nucleus accumbens
17. Efferent projections of the subthalamic nucleus in the rat: Light and electron microscopic analysis with the PHA-L method
18. Perikaryal neurofilament phosphorylation in axotomized and 6-OH-dopamine-lesioned CNS neurons
19. Aberrant phosphorylation of neurofilaments accompanies transmitter related changes in rat septal neurons following transection of the fimbria fornix
20. Movement disorders following lesions of the thalamus or subthalamic region
21. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease
22. Pathological diagnostic criteria for dementia associated with cortical Lewy bodies: Review and proposal for a descriptive approach
23. Protein measurement with the folin phenol reagent
24. 2 receptor control of pallidal fos expression: Comparisons between intact and 6-hydroxydopamine-treated hemispheres
25. Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: Autoradiographic analysis
26. Effects of dopamine depletion on the morphology of medium spiny neurons in the shell and core of the rat nucleus accumbens
27. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey
28. Long-lasting transneuronal dendritic changes of GABAergic neurons in the monkey dentate gyrus following entorhinal cortex lesion
29. Nerve growth factor receptor immunoreactivity within the nucleus basalis (Ch4) in Parkinson's disease: Reduced cell numbers and colocalization with cholinergic neurons
30. Dopamine in the rat ventral pallidum/substantia innominata: Biochemical and electrophysiological studies
31. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404
32. Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in the rat
33. Disappearance of GAD-mRNA and tyrosine hydroxylase in substantia nigra following striatal ibotenic acid lesions: Evidence for transneuronal regression
34. Cortical projections arising from the basal forebrain: A study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase
35. Rapid in vitro modulation of [3H]hemicholinium-3 binding sites in rat striatal slices
36. Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin fixed normal and Alzheimer's disease brain tissues
37. Local and distant histopathological effects of unilateral amyloid-β 25-35 injections into the amygdala of young F344 rats
38. Hemicholinium-3 binding: Correlation with high affinity choline uptake during changes in cholinergic activity
39. Hippocampal pyramidal cell response to 6-hydroxydopamine lesions of the rat ventral tegmental area
40. Neuronal argyrophilia and phosphorylated neurofilament accumulation secondary to deafferentation
41. AMPA and NMDA receptors mediate the response of ventral pallidal neurons to electrical activation of the subthalamic nucleus
42. 6-OHDA-induced lesions in the substantia nigra enhance ventral pallidal neuronal responses to NMDA
43. Parkinson's disease
44. The effects of kainic acid and 6-hydroxydopamine lesions, metal ions and GTP on in vitro binding of the D-2 dopamine agonist, [3H]N-0437, to striatal membranes
45. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism
46. Catecholaminergic-cholinergic interaction in the basal forebrain